SPONSOR
The Netherlands Cancer Institute
Total Trials
4
Recruiting
4
Phases
Phase 4, Phase 2
Conditions studied: Erectile Dysfunction Following Radical ProstatectomyOrgan PreservationRectal CancerQuality of LifeLocally Advanced Rectal CarcinomamCRPCMale Urogenital DiseasesLocally Advanced, Squamous Cell Carcinoma of the Vulva
The Netherlands Cancer Institute is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Erectile Dysfunction Following Radical Prostatectomy, Organ Preservation, Rectal Cancer, Quality of Life.
The trial portfolio spans Phase 4, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The Netherlands Cancer Institute
How many clinical trials has The Netherlands Cancer Institute sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by The Netherlands Cancer Institute, of which 4 are actively recruiting participants. These trials cover conditions including Erectile Dysfunction Following Radical Prostatectomy, Organ Preservation, Rectal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The Netherlands Cancer Institute research focus on?
The Netherlands Cancer Institute clinical trials span Erectile Dysfunction Following Radical Prostatectomy, Organ Preservation, Rectal Cancer, Quality of Life, Locally Advanced Rectal Carcinoma, and additional conditions. The research pipeline includes Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The Netherlands Cancer Institute clinical trial?
To participate in a The Netherlands Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The Netherlands Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by The Netherlands Cancer Institute
NCT06875258 Phase 4
Recruiting
PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)
Erectile Dysfunction Following Radical Prostatectomy
NCT05772923
Recruiting
Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision
Organ Preservation
NCT06659926
Recruiting
The Radium-select Study
mCRPC
NCT04192253 Phase 2
Recruiting
Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize)
Locally Advanced, Squamous Cell Carcinoma of the Vulva
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology